Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphoid 1Hematologic Diseases 1

Interventions

ibrutinib 4fludarabine phosphate 4fludarabine 4Rituximab 4Bendamustine Hydrochloride 3blinatumomab 2Melphalan 2Lenalidomide 2Cyclophosphamide 2Busulfan 2Alemtuzumab 2thymoglobulin 1sargramostim 1pirtobrutinib 1pegaspargase 1palbociclib 1ofatumumab 1obinutuzumab 1lirilumab 1copanlisib 1Vincristine 1RFT5-SMPT-dgA immunotoxin 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Methotrexate 1Mesna 1Leukapheresis 1Immunotherapy, Adoptive 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Lymphoid × pirtobrutinib × Clear all
NCT04849416 2026-02-06

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

Eli Lilly and Company

Phase 2 Completed
87 enrolled 19 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡